Eun-Sun Kim
Président chez Boryung Holdings Co., Ltd.
Fortune : 53 M $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Gwang-Sup Gil | M | 76 | 11 ans | |
| Seung-Ho Kim | M | 92 |
Boryung Holdings Co., Ltd.
 Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | 12 ans |
| Eun-Jung Kim | F | 54 |
Boryung Biopharma Co. Ltd.
 Boryung Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Boryung Holdings Co., Ltd., Boryung Biopharma Co. Ltd. is a South Korean company that manufactures and markets oral typhoid vaccines. The company is based in Jongno, South Korea. The company was founded in 1991 by Soung-Ho Kim. | 12 ans |
| Han-Bok Lee | M | 70 | 11 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Kwang-Ho Kim | M | 76 | - | |
| Young-Ha Kim | M | 69 | - | |
| Tae-Hong Choi | M | 67 | 6 ans | |
| Jae-Hyeon Ahn | M | 62 | - | |
| Heng-Seop Jin | M | 78 | - | |
| Jung-Kyun Kim | M | - |
Boryung Holdings Co., Ltd.
Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Corée du Sud | 10 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Eun-Sun Kim
- Réseau Personnel
